Physician profile
Jennifer Evans
NPI 1952950263
$1,433.05
in general payments reported to CMS, 2019-2025
17 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $540 · 2022: $219 · 2023: $207 · 2024: $254 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598 · Education: $75.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.90 |
| Education | $75.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $382.72 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $261.83 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $167.08 | 2021-2024 | Mounjaro, Zepbound |
| Becton, Dickinson and Company | $125.30 | 2021-2022 | |
| Astellas Pharma US INC | $75.99 | 2025 | |
| Merck Sharp & Dohme LLC | $75.89 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $65.34 | 2021 | |
| Abbvie INC. | $49.91 | 2023 | |
| Indivior INC. | $47.28 | 2023 | Perseris |
| Organon LLC | $36.52 | 2022-2023 | Nexplanon |
| Janssen Pharmaceuticals, INC | $35.93 | 2021-2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $22.46 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.93 | 2022 | |
| Amgen INC. | $20.75 | 2024 | Repatha, Otezla |
| Qiagen, LLC | $16.34 | 2023 | Quantiferon-Tb Gold Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.96 | 2023 | Doc Band |
| Glaxosmithkline, LLC. | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.